Feryxia 210mg Tablet contains an active component as Ferric citrate. It is a medication used to treat iron deficiency anaemia and hyperphosphatemia (increased phosphate levels in the body). It is a phosphate binder prescribed to manage hyperphosphatemia in chronic kidney patients undergoing dialysis. It is also an iron supplement that provides the elemental iron necessary to produce red blood cells. Iron is necessary for producing haemoglobin, a protein in red blood cells that carries oxygen throughout the body and is also an essential nutrient for overall energy production and metabolism. This medication is commonly prescribed when oral iron supplements alone are not sufficient or well-tolerated. Inform your healthcare provider about any pre-existing medical conditions, such as gastrointestinal disorders, liver disease, kidney disease, or other health conditions. These may require special precautions or adjustments in the use of Feryxia 210mg Tablet. Certain gastrointestinal disorders, such as ulcerative colitis, Crohn's disease, or other iron absorption conditions, may require special caution when using Feryxia 210mg Tablet. The underlying condition should be managed and optimised before considering iron supplementation. If you have a known allergy or hypersensitivity to Feryxia 210mg Tablet or other ingredients in the medication, you should avoid its use. This medication should not be used in individuals with iron overload conditions such as hemochromatosis, hemosiderosis, or other conditions that cause excessive iron accumulation in the body.